Use of propofol in pediatric intensive care units: A national survey in Germany

Pediatric Critical Care Medicine

Volumn 13, Issue 3, 2012, Pages

  Kruessell, Markus A ^a   Udink Ten Cate, Floris E A ^a   Kraus, Anna Julia ^a   Roth, Bernhard ^a   Trieschmann, Uwe ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

off label use; pediatric intensive care units; propofol; propofol infusion syndrome; sedation; survey

Indexed keywords

4 HYDROXYBUTYRIC ACID; ALFENTANIL; ETOMIDATE; FENTANYL; KETAMINE; MIDAZOLAM; MORPHINE; PROPOFOL; REMIFENTANIL; SUFENTANIL; THIOPENTAL;

ACIDOSIS; ADOLESCENT; AIR CONDITIONING; BRONCHOSPASM; CONTINUOUS INFUSION; DRUG INDICATION; DRUG SAFETY; DRUG USE; EPILEPTIC STATE; EXTUBATION; GERMANY; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; QUESTIONNAIRE; REVIEW; SEDATION; THROMBOPHLEBITIS; TREATMENT DURATION; VOMITING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; GERMANY; HEALTH CARE SURVEYS; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE UNITS, PEDIATRIC; OFF-LABEL USE; PROPOFOL; QUESTIONNAIRES;

EID: 84861201360     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3182388a95     Document Type: Review

References (23)

1. AstraZeneca UK Limited: Diprivan 1%. Summary of Product Characteristics. 15/09/2010. Available at: http://www.medicines.org.uk/ EMC/medicine/2275/SPC/ Diprivan+1. Accessed June14, 2011
2. MedWatch-The FDA Safety Information and Adverse Event Reporting Program: Diprivan (propofol) April 25, 2001 (Letter-AstraZeneca Pharmaceuticals). Available at: http://www. fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ ucm172351.htm. Accessed June 14, 2011
3. Committee on safety of medicines: Propofol (Diprivan) infusion: Sedation in children aged 16 years or younger contraindicated. Current problems in pharmacovigilance: 2001. Available at: http://www.mhra.gov. uk/Publications/ Safetyguidance/Current ProblemsinPharmacovigilance/CON007455. Accessed June 14, 2011
4. Parke TJ, Stevens JE, Rice AS, et al: Metabolic acidosis and fatal myocardial failure after propofol infusion in children: Five case reports. BMJ 1992; 305:613-616
5. Bray RJ: Propofol infusion syndrome in children. Paediatr Anaesth 1998; 8:491-499 (Pubitemid 28523410)
6. Vasile B, Rasulo F, Candiani A, et al: The pathophysiology of propofol infusion syndrome: A simple name for a complex syndrome. Intensive Care Med 2003; 29:1417-1425 (Pubitemid 37153585)
7. Wolf A, Weir P, Segar P, et al: Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 2001; 357:606-607 (Pubitemid 32179617)
8. Martin PH, Murthy BV, Petros AJ: Metabolic, biochemical and haemodynamic effects of infusion of propofol for long- term sedation of children undergoing intensive care. Br J Anaesth 1997; 79:276-279 (Pubitemid 27404035)
9. Prins SA, Peeters MY, Houmes RJ, et al: Propofol 6% as sedative in children under 2 years of age following major craniofacial surgery. Br J Anaesth 2005; 94:630-635 (Pubitemid 40613809)
10. Cornfeld DN, Tegtmeyer K, Nelson MD, et al: Continuous propofol infusion in 142 critically ill children. Pediatrics 2002; 110:1177-1181 (Pubitemid 35425194)
11. Rigby- Jones AE, Nolan JA, Priston MJ, et al: Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit. Anesthesiology 2002; 97:1393-1400 (Pubitemid 35417436)
12. Pepperman ML, Macrae D: A comparison of propofol and other sedative use in paedi-atric intensive care in the United Kingdom. Paediatr Anaesth 1997; 7:143-153 (Pubitemid 27241685)
13. Sheridan RL, Keaney T, Stoddard F, et al: Short- term propofol infusion as an adjunct to extubation in burned children. J Burn Care Rehabil 2003; 24:356-360 (Pubitemid 37444510)
14. Haase R, Sauer H, Eichler G: Lactic acidosis following short- term propofol infusion may be an early warning of propofol infusion syndrome. J Neurosurg Anesthesiol 2005; 17:122-123 (Pubitemid 40602765)
15. Festa M, Bowra J, Schell D: Use of propofol infusion in Australian and New Zealand pae-diatric intensive care units. Anaesth Intensive Care 2002; 30:786-793 (Pubitemid 35469718)
16. Playfor SD, Venkatesh K: Current patterns of propofol use in PICU in the United Kingdom and North America. Paediatr Anaesth 2004; 14:501-504 (Pubitemid 38758672)
17. Merz TM, Regli B, Rothen HU, et al: Propofol infusion syndrome-a fatal case at a low infusion rate. Anesth Analg 2006; 103:1050 (Pubitemid 44576741)
18. Mehta N, DeMunter C, Habibi P, et al: Short- term propofol infusions in children. Lancet 1999; 354:866-867 (Pubitemid 29415604)
19. Kill C, Leonhardt A, Wulf H: Lacticacidosis after short- term infusion of propofol for anaesthesia in a child with osteogenesis imper-fecta. Paediatr Anaesth 2003; 13:823-826 (Pubitemid 37475884)
20. Koch M, De Backer D, Vincent JL: Lactic aci-dosis: An early marker of propofol infusion syndrome? Intensive Care Med 2004; 30:522 (Pubitemid 38375635)
21. Westhout FD, Muhonen MG, Nwagwu CI: Early propofol infusion syndrome following cerebral angiographic embolization for giant aneurysm repair. Case report. J Neurosurg 2007; 106:139-142
22. Laquay N, Pouard P, Silicani MA, et al: Early stages of propofol infusion syndrome in pae-diatric cardiac surgery: Two cases in adolescent girls. Br J Anaesth 2008; 101:880-881
23. Roberts RJ, Barletta JF, Fong JJ, et al: Incidence of propofol- related infusion syndrome in critically ill adults: A prospective, multicenter study. Crit Care 2009; 13:R169